ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 166 filers reported holding ALLAKOS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $530,280 | +291.7% | 119,164 | +641.1% | 0.00% | +200.0% |
| Q4 2022 | $135,385 | -91.6% | 16,079 | -93.9% | 0.00% | -88.9% |
| Q3 2022 | $1,604,000 | +381.7% | 262,098 | +146.7% | 0.01% | +350.0% |
| Q2 2022 | $333,000 | -74.0% | 106,245 | -52.8% | 0.00% | -81.8% |
| Q1 2022 | $1,283,000 | +122.0% | 225,149 | +281.0% | 0.01% | +120.0% |
| Q4 2021 | $578,000 | -27.5% | 59,089 | +684.5% | 0.01% | -50.0% |
| Q3 2021 | $797,000 | -78.7% | 7,532 | -82.8% | 0.01% | -76.2% |
| Q2 2021 | $3,742,000 | +2329.9% | 43,835 | +3156.7% | 0.04% | +2000.0% |
| Q1 2021 | $154,000 | -79.6% | 1,346 | -75.1% | 0.00% | -80.0% |
| Q4 2020 | $756,000 | +152.0% | 5,400 | +46.4% | 0.01% | +150.0% |
| Q3 2020 | $300,000 | -26.8% | 3,689 | -59.9% | 0.00% | -63.6% |
| Q1 2020 | $410,000 | +16.8% | 9,206 | +150.0% | 0.01% | +83.3% |
| Q4 2019 | $351,000 | -3.8% | 3,683 | -20.6% | 0.01% | -14.3% |
| Q3 2019 | $365,000 | – | 4,637 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |